4 completed, 2 recruiting. 1 Early Phase 1, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Completed 1 |
| Not applicable | 1 | Completed 1 |
Follow Stage I Ovarian Cancer: new trials by email Literature Review of Stage I Ovarian Cancer trials Research Report on Stage I Ovarian Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Prospective Multicenter Diagnostic Biomarker Study to Discriminate Borderline From Stage I Invasive Ovarian Cancer Stage I Ovarian Cancer, Borderline Ovarian Tumors | Recruiting | KU Leuven | 400 | 2025-06-03 | 2026-05-22 | |
| Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer Uterine lavage, or a wash of the womb, Blood sample, Pap smear - Ovarian Neoplasms, Ovarian Epithelial Carcinoma | Recruiting | Massachusetts General Hospital | 250 | 2020-04-13 | 2025-09-16 | |
| Intravital Microscopy in Evaluating Patients With Primary Peritoneal, Fallopian Tube, or Stage IA-IV Ovarian Cancer Diagnostic Microscopy, Fluorescein Sodium Injection, Laboratory Biomarker Analysis - Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma | Early Phase 1 | Completed | Roswell Park Cancer Institute | 19 | 2017-11-06 | 2021-10-06 |
| Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer Survivors Informational Intervention - Stage I Breast Cancer, Stage I Cervical Cancer | Not applicable | Completed | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 40 | 2015-08-01 | 2025-04-29 |
| Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy Cognitive Assessment, Quality-of-Life Assessment - Cognitive Side Effects of Cancer Therapy, Malignant Ovarian Epithelial Tumor | Completed | Gynecologic Oncology Group | 247 | 2010-04-01 | 2018-04-12 | |
| Collecting Tumor Samples From Patients With Gynecological Tumors Laboratory Biomarker Analysis - Borderline Ovarian Clear Cell Tumor, Borderline Ovarian Serous Tumor | Completed | Gynecologic Oncology Group | 275 | 1992-06-01 | 2016-10-28 |
Ovarian Neoplasms (6) · Fallopian Tube Neoplasms (4) · Brenner Tumor (2) · Uterine Cervical Neoplasms (2) · Breast Neoplasms (1) · Carcinoma, Ovarian Epithelial (1) · Disease (1) · Dysgerminoma (1) · Gestational Trophoblastic Disease (1) · Melanoma (1) · Mesothelioma, Malignant (1) · Neoplasms (1) · Ovarian Diseases (1) · Ovarian Germ Cell Cancer (1) · Sarcoma, Endometrial Stromal (1)
Adnexal Diseases (6) · Endocrine Gland Neoplasms (6) · Endocrine System Diseases (6) · Female Urogenital Diseases (6) · Female Urogenital Diseases and Pregnancy Complications (6) · Genital Diseases (6) · Genital Diseases, Female (6) · Genital Neoplasms, Female (6) · Gonadal Disorders (6) · Neoplasms by Site (6) · Urogenital Diseases (6) · Urogenital Neoplasms (6) · Neoplasms (5) · Ovarian Diseases (5) · Fallopian Tube Diseases (4)
Blood Specimen Collection (1) · Fluorescein (1) · Fluoresceins (1) · Mental Status and Dementia Tests (1) · Papanicolaou Test (1)
Gynecologic Oncology Group (2) · KU Leuven (1) · Massachusetts General Hospital (1) · Roswell Park Cancer Institute (1) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1)
United States (5) · Belgium (1) · Czechia (1) · Italy (1)
An Coosemans (1) · Andrea Barsevick, PhD (1) · Christos Patriotis, PhD (1) · Emese Zsiros, MD (1) · Lisa Hess (1) · Michael Cibull (1)
U01CA152990 (1), U10CA101165 (1), U10CA180868 (1), U2CCA271871 (1)